BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Drug Development

  Mustang Bio Reports Preclinical Data on Regional Delivery of MB-103 HER2 Chimeric Antigen Receptor Engineered T (CAR T) Cells to Target HER2+ Breast Cancer Metastasis to the Brain

  The data supports clinical development of MB-103 HER2 CAR T cell therapy.

  October 31, 2017

   · 

  4 min read
• Business

  Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2017 Financial Results

  The company has focused on quality execution of our clinical studies in postpartum depression, which will inform our later stage clinical development plans for this important underserved patient population.

  October 31, 2017

   · 

  9 min read
• Business

  Recro Pharma Reports Inducement Grants for New Staff - Oct. 31, 2017

  The company announced the expansion of its team through the employment of eight new employees in the areas of sales and marketing.

  October 31, 2017

   · 

  4 min read
• Eisai to Present Latest Data at 10th Clinical Trials on Alzheimer’s Diesase

  Eisai announced today that the latest data on its oral dual orexin receptor antagonist lemborexant and its oral beta secretase cleaving enzyme inhibitor elenbecestat(1) will be presented at the 10th Clinical Trials on Alzheimer’s Disease, taking place in Boston, the United States, from November 1 to 4.

  October 31, 2017

   · 

  2 min read
• Biotech Beach

  Agenda Announced for CTS Southern California 2017

  Building on the success of the Clinical Trial Supply Conference last November, we are delighted to announce that the 7th annual event will return to San Diego on 29th - 30th of November 2017.

  October 31, 2017

   · 

  1 min read
• Business

  BioGeneration Ventures Fund III Reaches EUR 82 Million in Final Close

  Due to strong market interest, the fund has exceeded its original target of EUR 50 million.

  October 31, 2017

   · 

  4 min read
• Business

  Collegium to Host Conference Call to Discuss Third Quarter 2017 Financial Results and Provide Corporate Update

  The Company will discuss its financial results and provide a corporate update.

  October 31, 2017

   · 

  1 min read
• Business

  Alliqua BioMedical to Announce Third Quarter of Fiscal Year 2017 Results on November 9th

  The CEO and CFO will host a teleconference at 8:00 a.m. Eastern Time on November 9th to discuss the results.

  October 31, 2017

   · 

  1 min read
• Drug Development

  Mobius Theraputics Release: Mitosol’s Orphan Drug Designation is Expanded for All Glaucoma Surgery

  By expanding this orphan drug indication, Mobius Therapeutics may now assume the benefits of orphan drug designation for new and evolving MIGS procedures used in the treatment of glaucoma.

  October 31, 2017

   · 

  1 min read
• Business

  Achaogen to Host Conference Call and Webcast of Third Quarter 2017 Financial Results on November 8, 2017

  Management will host a conference call and webcast discussion of the results and provide a general corporate update.

  October 31, 2017

   · 

  2 min read